Day
[용어속성] Term
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
24 hour
Ability
absence
accompany
activity
Administered
administration
Admission
adverse events
Affect
age
alkaline phosphatase
allergy
ALT
alternative hypothesis
ambient
Analysis
ANC
Anti-inflammatory
anticipated
antipyretics
antivirals
Arm
ARMS
assumed
AST
Baltimore
baseline
benefit
blinded
block
block randomization
Blood
breastfeeding women
Bronchoalveolar lavage
calculated
Care
Cellulose
center
Chest
chest X-ray
childbearing potential
clinical
clinical condition
Clinical course
clinical impact
Clinical improvement
Clinical outcome
clinical status
clinical trial
collected
competing
Compliance
concealed
Concentration
Concomitant
conditions
conducted
congestive heart failure
Contraception
Control
control arm
Conventional
Corticosteroids
COVID-19
COVID-19 disease
COVID-19 infection
COVID-19 pandemic
criteria
criterion
Critical
CT scan
current
Day
Declaration of Helsinki
decrease
defined
detect
direct bilirubin
disease
disorder
dissemination
dose
double-blind
drug
Drug administration
drug-drug interaction
drugs
Duration
ECMO
Efficacy
Efficacy and safety
element
eligible
endosomal pH
Enrollment
ethnic group
evaluate
Evidence
exclusion
expected
exploratory endpoint
extracorporeal membrane oxygenation
Face mask
FDA
Fisher
Good
group
handling
harmonization
hematologic
histocompatibility complex
Hospitalization
Hospitalized
hospitalized patient
Hydroxychloroquine
Hypothesis
ICU
IL-6 levels
Imatinib
immunomodulatory
immunomodulatory drugs
IND
information
Informed consent
inhibitory activity
intensive care
intensive care unit
intention to treat
interfere
International Conference
invasive
Invasive mechanical ventilation
investigational agent
investigator
ITT
Laboratory
Last
limit
limitation
liver
Local
lysosomal sequestration
magnitude
matching placebo
mechanical ventilation
men and women
MHC
mononuclear cell
Mortality
nasal
nasopharyngeal
Nasopharyngeal swab
neutrophil count
New
new oxygen use
non-invasive ventilation
non-rebreather mask
not blinded
null hypothesis
number
objective
off-label
off-label use
Oropharyngeal
outcome
outcomes
oxygen
Oxygenation
P450
packaged
PaO
participant
Participants
Patient
patients
patients with ARDS
patients with COVID-19
PBMCs
performed
Pharmacist
Pharmacy
phase 3 study
Placebo
placebo-controlled
Pneumonia
positive COVID-19
Practice
primary analysis
primary endpoint
principal
progression
proportion
protocol
Psychiatric
Radiographic
random number generator
randomised controlled trial
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
Regulatory
renal dysfunction
renal replacement therapy
replication of SARS-CoV-2
required
requiring supplemental oxygen
Respiratory illness
respiratory tract
risk
RT-PCR
Safety
Sample size
sarilumab
SARS-CoV
SARS-CoV-2
secondary endpoint
Seizure
Serious Adverse Events
service
severe disease
severity
significance level
Site
Society
stability
Standard of care
status
stratified
study drug
study enrollment
study outcomes
Study protocol
subject
submitted
supplemental oxygen
Support
Suspension
symptomatic
Tablet
temperature
Test
the patient
the primary endpoint
time
TKI
TKI-induced attenuation of vascular leak
TKI-induced prevention and treatment lung inflammation
Tocilizumab
transcriptomics
Treatment
treatment allocation
treatment arm
treatments for COVID-19
Trial
two-sided
tyrosine kinase inhibitor
uncontrolled
university
unstable angina
vasopressors
ventilator
ventilator free days
viral ABL-1 signalling
website
with COVID-19
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
Compare the epidemiological and clinical features of imported and local COVID-19 cases in Hainan, China
Short Report
[키워드] analysed
China
Clinical characteristics
clinical feature
Clinical features
clinical manifestations
coronavirus disease
Coronavirus disease 2019
cough
COVID-19
COVID-19 case
Day
declined
described
diagnosed
died
discharge
Epidemic
epidemiological
Epidemiology
feature
Fever
Follow-up
Hainan
hospital
IgG
IgG antibody
IgG level
imported case
incidence
infections
information
intensive care
International
laboratory characteristics
levels of antibody
Local
management
measure
median
medical records
Nasopharyngeal swab
nine
no difference
occurred
Off
Older
outcome
Patient
patients
positive
Prevention and control
reduction in
reported
Result
severe acute respiratory syndrome coronavirus 2
the epidemic
the median
two groups
viral shedding
[DOI] 10.1186/s40249-020-00755-7 PMC 바로가기 [Article Type] Short Report
[DOI] 10.1186/s40249-020-00755-7 PMC 바로가기 [Article Type] Short Report
An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
7-point ordinal scale
adaptive
Alfred Hospital
allergy
Antiviral
Antiviral treatment
Arm
biomarkers of inflammation
blinded to treatment
childbearing potential
clinical
clinical benefit
clinical symptom
clinical trial
Community
Confirmed
Contraception
COVID-19
COVID-19 infection
Day
defined
determine
dialysis
dissemination
dose
effective
Efficacy
element
eligible
enrolled
enrolment
Favipiravir
female
fertile
GRADE
hospitalisation
hospitalised
immune activation
ineligible
investigator
male
medication
negative pregnancy test
nucleic acid
number
objective
outcome
parallel-group
participant
Participants
Patient
performed
Pharmacy
Placebo
protocol
randomisation
randomised
randomised controlled trial
recruit
recruited
recruitment
renal impairment
Sample size
SARS-CoV-2
Screening
secondary
severe hepatic dysfunction
Standard of care
status
stratified
Study protocol
study visit
Swab
Symptom
the WHO
time
Treatment
Trial
triple-blind
Victoria
virological cure
website
[DOI] 10.1186/s13063-020-04766-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04766-5 PMC 바로가기 [Article Type] Letter
Correlates of Health-Protective Behavior During the Initial Days of the COVID-19 Outbreak in Norway
Psychology
[키워드] Behavior
change
changes in
Combination
concern
coronavirus
COVID-19
COVID-19 outbreak
Day
declined
demographic characteristics
demographic factor
Demographic factors
Drawing
effective
exploratory
Guidance
Health
Health protective behavior
hygiene
indication
Infection
Intervention
investigated
knowledge
mandatory
manifested
measure
media
Norway
Norwegian
outbreak
over
Pandemics
Perceived risk
physical distancing
positive
Previous studies
Psychological
recruited
replicated
reported
risk
Spread
spread of COVID-19
traditional method
variable
[DOI] 10.3389/fpsyg.2020.564083 PMC 바로가기 [Article Type] Psychology
[DOI] 10.3389/fpsyg.2020.564083 PMC 바로가기 [Article Type] Psychology
Turnaround times – the Achilles’ heel of community screening and testing in Cape Town, South Africa: A short report
Short Report
Published on
Journal: African Journal of Primary Health Care & Family Me [Category] COVID-19, MERS, SARS,
Journal: African Journal of Primary Health Care & Family Me [Category] COVID-19, MERS, SARS,
[키워드] acute respiratory syndrome
approach
Cape
Cape Town
changed
Community
community screening and testing
Contact
contributed
coronavirus infection disease
Coronavirus-2
Course
COVID-19
CST
Day
Delft
Department
employer
first positive
had no
high-risk patient
include
issue
Local
median
pandemic
Patient
patients
peaking
polymerase chain
positive
primary care
problems
SARS-CoV-2
scaled
Self-isolation
sick
South
South Africa
Spread
TAT
tested
town
transcriptase
turnaround time
turnaround times
Viral transport medium
[DOI] 10.4102/phcfm.v12i1.2624 PMC 바로가기 [Article Type] Short Report
[DOI] 10.4102/phcfm.v12i1.2624 PMC 바로가기 [Article Type] Short Report
A COVID-19 Outbreak in a Rheumatology Department Upon the Early Days of the Pandemic
Medicine
[키워드] absence
acute respiratory syndrome
age
Asymptomatic
clinically
complete recovery
Contact
coronavirus
coronavirus disease
cough
COVID-19
COVID-19 outbreak
COVID-19 symptom
COVID-19 symptoms
Day
Department
Dyspnea
excluded
female
Fever
HCW
HCWs
healthcare worker
healthcare workers (HCW)
Hospitalization
humoral
IgG
immune response
individual
individuals
Mild disease
moderate disease
naso-oropharyngeal swab
occur
outbreak
pandemic
patients
positive
post-symptom onset
presymptomatic
presymptomatic transmission
repeated
Rheumatic patients
rheumatology
rheumatology practice
risk
RT-PCR
SARS-CoV-2
screened
serological response
severe complications
Symptom
symptom duration
symptomatic
tested
Transcription
typical symptom
viral shedding
[DOI] 10.3389/fmed.2020.576162 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2020.576162 PMC 바로가기 [Article Type] Medicine
Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during coronavirus disease 2019 pandemic: a case report
Case Report
[키워드] adverse events
affected
Aortic stenosis
balloon
Balloon aortic valvuloplasty
Case report
Clinical course
condition
coronavirus disease
COVID‐19
COVID‐19
Day
decompensated heart failure
Deterioration
high risk
Nasopharyngeal swab
Novel coronavirus
outbreak
pandemic
Patient
SARS‐CoV‐2
the patient
Transcatheter aortic valve implantation
Treatment
valvuloplasty
[DOI] 10.1002/ehf2.13003 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1002/ehf2.13003 PMC 바로가기 [Article Type] Case Report
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark
Letter
[키워드] 1:1
24 hour
Administered
administration
age
All participant
allergy
anti-cytokine therapy
approved
asked
Bacterial infection
BCG
BCG vaccination
blinded to treatment
block
Bone marrow
Chemotherapy
component
Controlled trial
COVID-19
COVID-19 pandemic
criteria
cumulative
current
daily dose
Day
defined
Denmark
Direct
dissemination
dose
Effect
element
eligible
ENhance
EudraCT
excluded
exclusion
group
HCW
Health care
Health care worker
HIV-1
hospital
Hospital admission
hospitals
Human immunodeficiency virus
Immunocompromised
immunodeficiency
incidence
Inclusion
infected with SARS-CoV-2
Infection
infections
Infectious disease
injection
Intervention
intravenous
lymphoma
malignancy
Medicine
meet
morbidity and mortality
mycobacterial
Mycobacterium tuberculosis
NaCl solution
non-specific
not blinded
number
participant
physician
Placebo
Prednisone
Prevent
protective effect
protocol
random
randomisation
randomised
randomised controlled trial
receive
recruit
reduce
reductions in
Registered
reported
resuspended
Sample
secondary
Serious Adverse Event
severity of COVID-19
Sex
solid organ transplantation
steroid
Stratification
study participant
Study protocol
subject
subjects
susceptibility
suspicion
Treatment
Trial
Tuberculosis
Vaccine
Vaccines
website
[DOI] 10.1186/s13063-020-04714-3 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04714-3 PMC 바로가기 [Article Type] Letter
Mobile Health Apps on COVID-19 Launched in the Early Days of the Pandemic: Content Analysis and Review
Original Paper
[키워드] app
assessment criteria
automated
Care
conducted
connection
content
content analysis
coronavirus
coronavirus disease
country
COVID-19
COVID-19 cases
data entry
Day
dissemination
evaluate
feature
function
functions
Google Play
Health
health authorities
Health authority
Health Education
help
helping
identify
IMPROVE
inclusion criteria
information
knowledge
mHealth
Mobile
mobile medical app
modify
MOST
n=36
objective
outcome
outcomes
performed
professional
Result
review
scored
self-care
Surveillance
Symptom
The United States
was used
[DOI] 10.2196/19796 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.2196/19796 PMC 바로가기 [Article Type] Original Paper